(Q40927893)

24 September 2017

1 reference

title

Mechanisms of metformin action in non-insulin-dependent diabetes mellitus (English)

1 reference

24 September 2017

1 reference

Perriello G

1

1 reference

24 September 2017

1 September 1995

1 reference

Diabetes/metabolism reviews

24 September 2017

1 reference

24 September 2017

11 Suppl 1

1 reference

24 September 2017

S51-6

1 reference

Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine

24 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

Anti-diabetic biguanides inhibit hormone-induced intracellular Ca2+ concentration oscillations in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

Metformin increases insulin sensitivity and basal glucose clearance in Type 2 (non-insulin dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

Reconsideration of inhibitory effect of metformin on intestinal glucose absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Re-evaluation of a biguanide, metformin: mechanism of action and tolerability

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

The effect of biguanides on secretion and biosynthesis of insulin in isolated pancreatic islets of rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

The effect of metformin on the arginine induced insulin- and glucagon release in pigs

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Effect of metformin on hepatocyte insulin receptor binding in normal, streptozotocin diabetic and genetically obese diabetic (ob/ob) mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Insulin Receptor Binding to Monocytes, Insulin Secretion, and Glucose Tolerance Following Metformin Treatment: Results of a Double-Blind Cross-Over Study in Type II Diabetics

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Mechanism of Action of Metformin: Insulin Receptor and Postreceptor Effects in Vitro and in Vivo*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

The effect of metformin on glycaemic control, intermediary metabolism and blood pressure in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Carbohydrate metabolism in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Specific Inhibition of Gluconeogenesis by Biguanides

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Mode of action of hypoglycemic agents. IV. Control of the hypoglycemic activity of phenethylbiguanide in rats and guinea-pigs

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Effects of metformin on glucose and glucagon regulated gluconeogenesis in cultured normal and diabetic hepatocytes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Rat liver glycogen-lowering activity of fed creatine--a retraction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Sites of metformin-stimulated glucose metabolism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Association of Metformin's Effect to Increase Insulin-Stimulated Glucose Transport With Potentiation of Insulin-Induced Translocation of Glucose Transporters From Intracellular Pool to Plasma Membrane in Rat Adipocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Mechanism of metformin action in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Acute and chronic effects of hyperglycaemia on glucose metabolism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Effects of glucagon and long chain fatty acids on glucose production by isolated perfused rat liver

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110508

7 January 2021

Identifiers

DOI

10.1002/DMR.5610110508

1 reference

24 September 2017

1 reference

PubMed ID

8529485